Migraine: Molecular Basis and Herbal Medicine
Abstract
Migraine is a common and disabling brain disorder with no single characteristic which could be used for a definite diagnosis. Usually a combination of different presentations is used as diagnostic criteria which may lead to a challenging feature of underor misdiagnosis and also under-treatment. Diagnostic criteria for migraine usually emphasize on specificity compared to sensitivity which enhances their research values but reduces their clinical worth. The criteria are subjective and the lack of objective tests to confirm migraine diagnosis raises the need of rule out of other diagnoses. For this reason a potential diagnostic biomarker for migraine would certainly find wide application and may improve current severe deficiencies in migraine diagnosis.
Read the paper
Related studies
- Bioactive Molecules Released in Food by Lactic Acid Bacteria: Encrypted Peptides and Biogenic Amines
- A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications
- Bioaccessibility and bioavailability of phenolic compounds
- The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development
- Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery
- Effects of the Mediterranean Diet on the Components of Metabolic Syndrome Concerning the Cardiometabolic Risk
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.